Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Blue Light & Screens

Evening Light Exposure & Devices

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

17 human trials, about 150 studies, >3,000 participants. The written rationale for this grade is still being prepared.

FDA
Consumer products vary
WADA
Not prohibited

Reference only. Not medical advice.

What can go wrong

Blue-light glasses are widely oversold for screen use and general sleep. A 2023 Cochrane review and the American Academy of Ophthalmology find no good evidence they reduce eye strain or protect the eyes, and standard lenses block too little to meaningfully preserve melatonin. Brightness and behavioral arousal are the larger problems. A small number of trials suggest high-block amber lenses worn well before bed may help people with insomnia symptoms, but those samples are tiny. Persistent insomnia, mood changes, or sleep that does not improve with light and screen adjustments should be discussed with a qualified sleep clinician or physician rather than self-managed with consumer eyewear.

Evening light, especially short-wavelength blue near 460-480nm, suppresses melatonin and delays the clock through melanopsin-containing retinal cells, and that photobiology is well established. The popular focus on blue-light-blocking glasses is where evidence thins out. A 2023 Cochrane review of 17 randomized trials found blue-light-filtering lenses probably make no difference to eye strain, vision, or sleep, and the American Academy of Ophthalmology does not recommend them. Total brightness matters more than wavelength, ordinary room light around 25 lux can already cut melatonin in half on average, and the arousing nature of nighttime device content disrupts sleep independently of any light effect. Dimming all light and reducing pre-bed device use are associated with larger effects than relying on filters.

The wavelength gets the blame, but brightness, and what you do on the screen, matter more.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Protecting evening melatonin by dimming light
  • Supporting earlier sleep onset
  • Managing pre-bed device use and screen brightness
  • Clinical exploration of high-block amber lenses for insomnia symptoms under provider guidance

What people get wrong

  • Often saidBlue-light glasses solve evening screen problems

    ActuallyA 2023 Cochrane review of 17 randomized trials found blue-light-filtering spectacle lenses probably make no difference to eye strain, visual performance, or sleep quality, and gave no evidence of retinal protection (Singh, Downie et al., Cochrane Database Syst Rev). Standard consumer lenses also filter only a fraction of blue light. Dimming all light and reducing arousing screen use are associated with larger effects.

  • Often saidNight mode makes screens safe before bed

    ActuallyA randomized trial of 167 young adults found Apple Night Shift produced no difference in sleep versus phone use without it, and not using the phone at all was associated with the best sleep (Jensen et al. 2021, Sleep Health). Warm screen modes shift color but keep brightness up, and total brightness and behavioral arousal are the larger factors.

  • Often saidBlue light from screens damages the eyes

    ActuallyThe American Academy of Ophthalmology states there is no scientific evidence that light from computer screens damages the eyes and does not recommend blue-blocking glasses for screen use. Digital eye strain is associated mainly with reduced blinking and screen habits, not the wavelength itself.

  • Often saidOnly blue light matters at night

    ActuallyAny sufficiently bright light at night suppresses melatonin, not only blue. On average, half-maximal suppression occurs near 25 lux, comparable to dim indoor lighting (Phillips et al. 2019, PNAS), so total illuminance is the dominant lever and dimming is associated with larger effects than color filtering alone.

Who profits, and who pushes back

  • Sumeer Singh and Laura Downie, University of Melbourne (2023 Cochrane review)

    Pushes backLead and senior authors of the Cochrane systematic review of 17 RCTs of blue-light-filtering lenses

    The review concluded that blue-light-filtering spectacle lenses probably make no difference to eye strain, visual performance, or sleep quality, and that the evidence does not support prescribing them to the general population.

  • American Academy of Ophthalmology

    Pushes backProfessional body of ophthalmologists, public guidance on computer eyewear

    The Academy does not recommend blue light-blocking glasses, stating there is no scientific evidence that light from computer screens damages the eyes, and recommends screen-habit changes such as the 20-20-20 approach instead.

  • Chad Jensen, Brigham Young University (2021 Night Shift RCT)

    Pushes backLead author of a 167-person randomized trial of smartphone Night Shift and sleep

    Across the whole sample there were no differences in sleep among Night Shift users, non-Night-Shift phone users, and non-users, suggesting psychological engagement with the device matters as much as the light.

  • Blue-blocker eyewear industry

    Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.

    Promotes itCommercial

    Markets glasses heavily for sleep and eye strain; the strongest claims outrun the evidence, especially for low-block lenses.

  • Sleep-hygiene educators

    Promotes itMixed

    Emphasize dimming light and limiting pre-bed screens over relying on filters.

Where the research comes from

Share of published research by country of origin.
PlaceShare of published research
USA42%
Europe32%
Other26%

Research published from: Global.

How we got here

The science behind this topic is rooted in late-twentieth-century chronobiology. In 2000, Ignacio Provencio's group identified melanopsin, and in 2002 David Berson's lab confirmed intrinsically photosensitive retinal ganglion cells that signal light to the brain's clock independent of rods and cones. In 2001 two teams, George Brainard's in the United States and Kathryn Thapan with Josephine Arendt and Debra Skene in Britain, independently mapped the action spectrum for melatonin suppression, both pointing to short-wavelength light. As smartphones spread through the 2010s, these findings were translated, and frequently overstated, into a consumer market of blue-light-blocking glasses and device night modes. Closer study complicated the marketing. Brightness and the engaging, arousing nature of device use were recognized as larger factors than wavelength, and systematic reviews in 2017 and 2023 found little support for the lens claims, leaving the consumer fixes partly mismatched to the real problem.

  1. 2000Provencio and colleagues identify melanopsin, a novel photopigment
  2. 2001Brainard (US) and Thapan/Arendt/Skene (UK) independently map the melatonin-suppression action spectrum to short-wavelength light
  3. 2002Berson's lab confirms intrinsically photosensitive retinal ganglion cells that drive the circadian light response
  4. 2009Burkhart and Phelps report a small randomized trial of amber lenses improving sleep ratings
  5. 2011Gooley et al. show ordinary room light before bed suppresses and shortens melatonin
  6. 2015Chang et al. (PNAS) show evening light-emitting eReaders delay the clock and reduce melatonin versus print
  7. 2017Lawrenson, Hull and Downie systematic review finds little evidence for blue-blocking spectacle lenses
  8. 2019Phillips et al. (PNAS) report ~25 lux ED50 for melatonin suppression and a greater than 50-fold range across individuals
  9. 2021BYU RCT (Jensen et al., n=167) finds smartphone Night Shift makes no difference to sleep
  10. 2023Cochrane review of 17 RCTs concludes blue-light-filtering lenses probably make no difference to eye strain, vision, or sleep

At a glance

Most sensitive
~460-480nm (blue)
Bigger factor
Total brightness
Effective eyewear
>99% block (amber/red)
Confound
Psychological arousal

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Blue Light & Screens. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources